China Pharmaceutical Glass Packaging Industry Report, 2013-2016
  • Apr./2014
  • Hard Copy
  • USD $1,600
  • Pages:53
  • Single User License
    (PDF Unprintable)       
  • USD $1,500
  • Code: ZYM054
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,300
  • Hard Copy + Single User License
  • USD $1,800
      

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly. In 2013, China’s pharmaceutical glass bottle market capacity amounted to 80 billion pieces with the weight of 250,000-300,000 tons.

Due to low entry barriers, Chinese pharmaceutical glass market is featured with serious overcapcity of medium and low-end products as well as the reliance of high-end products on imports. At present, developed countries prefer first-class waterproof neutral borosilicate glass, while China still in the main applies low borosilicate glass, sodium-calcium glass and "semi-neutral borosilicate glass" (its chemical stability can not meet neutral requirements; the heavy metal content in glass is not defined clearly; dimensions are not accurate). As for prefilled injection system glass, China mainly relies on the import from foreign brands such as German Schott.

The report involves the following:
20120114.gif  Market size, market demand, competition pattern, import & export and development trend of China pharmaceutical glass industry;
20120114.gif  Status quo, competition pattern and price analysis of China prefilled syringe industry;
20120114.gif  Operation, pharmaceutical glass business and development prospects of four global and six Chinese pharmaceutical glass packaging enterprises.

After years of development and competition, Chinese pharmaceutical glass market concentration degree is still not high, but there have been competitive leading players in some market segments mainly in Jiangsu, Zhejiang and Shandong.

Shandong Pharmaceutical Glass is the world's fifth and China's first medical glass (Class-I) producer. As one of top five Chinese prefilled syringe suppliers, Shandong Pharmaceutical Glass has the capacity of 50 million units/a, but it is still exploring the market with a rather low market share. Meanwhile, the company is a leading pharmaceutical molded bottle enterprise in China with the capacity of 10 billion units/a and about 70% market share.

Weigao is also one of the top five Chinese prefilled syringe suppliers. By virtue of preemptive advantages and perfect sales networks, Weigao sold 70 million prefilled syringes in 2013, holding about 60% market share in China.

German Schott has transferred from simple high-end pharmaceutical glass raw material supply to the combination of raw material supply and joint production of finished products. Its joint venture in China -- Schott Xin Kang Pharmaceutical Packaging Co., Ltd. can produce 1-1.5 billion pharmaceutical glass bottles (vials and ampule bottles) each year.

Germany Gerresheimerd conducts Plastic Systems, Moulded Glass, Tubular Glass and Life Science Research in China. However, the prefilled syringes from the company in China are not made in China but imported. In addition, Gerresheimerd and Shuangfeng Glass founded a high-end medical packaging material joint venture -- Gerresheimer Shuangfeng that has two subsidiaries located in Danyang city and Zhenjiang city, as well as three production sites (two in Danyang and one in Zhenjiang).

2014040402.png

1 Overview of Pharmaceutical Glass Packaging Materials 
1.1 Definition and Classification 
1.2 Industry Chain

2 Development of China Pharmaceutical Glass Industry
2.1 Status Quo 
2.2 Market Size 
2.3 Competition Pattern 
2.4 Import and Export 
2.5 Prefilled Syringe 
2.5.1 Definition and Classification
2.5.2 Status Quo 
2.5.3 Competition Pattern 
2.5.4 Price Analysis 
2.6 Development Trend 

3 Major Pharmaceutical Glass Enterprises 
3.1 Becton, Dickinson and Company
3.1.1Profile 
3.1.2 Operation 
3.1.3 Revenue Structure 
3.1.4 Pharmaceutical Packaging Materials Business 
3.1.5 Business in China 
3.2 Gerresheimer AG
3.2.1 Profile 
3.2.2 Operation 
3.2.3 Revenue Structure 
3.2.4 Business in China 
3.3 SCHOTT AG
3.3.1 Profile 
3.3.2 Pharmaceutical Packaging Materials Business 
3.3.3 Business in China 
3.4 Nipro Medical Corporation
3.4.1 Profile 
3.4.2 Operation 
3.4.3 Revenue Structure 
3.4.4 Pharmaceutical Packaging Materials Business 
3.4.5 Business in China 
3.5 Shandong Pharmaceutical Glass 
3.5.1 Profile 
3.5.2 Operation 
3.5.3 Revenue Structure 
3.5.4 Gross Margin 
3.5.5 Prospects and Forecast 
3.6 Weigao 
3.6.1 Profile 
3.6.2 Operation 
3.6.3 Revenue Structure 
3.6.4 Gross Margin 
3.6.5 R & D and Investment 
3.6.6 Major Clients 
3.6.7 Pharmaceutical Packaging Materials Business 
3.6.8 Prospects and Forecast 
3.7 Cangzhou Four Stars Glass
3.8 Min Kang Pharmaceutical 
3.9 ChongQing ZhengChuan Glass
3.10 Linuo Group
Classification and Application of Pharmaceutical Glass
New-type Pharmaceutical Glass Packaging and Application
Pharmaceutical Glass Packaging Industry Chain
Output of Human Powder (Including Lyophiled Powder) and Injection in China, 2010-2013
China’s Human LVP Output, 2010-2013
Revenue and YoY Growth Rate of Chinese Veterinary Drug industry, 2007-2013 
China’s Glass Ampule Import and Export Volume, 2011-2013 
China’s Glass Ampule Import and Export Value, 2011-2013
China’s Glass Ampule Import and Export Average Price, 2011-2013
Prefilled Syringe-use Materials 
Prefilled Syringe Classification and Structure
Chinese Prefilled Syringe Suppliers and Their Products
Major Chinese Prefilled Enterprises and Their Capacity, 2013
Prices of Some Chinese Prefilled Pharmaceutical Packaging Products, 2010-2013
BD's Main Businesses 
BD's Revenue and Operating Profit, FY2010-FY2013 
BD's Revenue Structure (by Business), FY2012-FY2013 
BD's Revenue Structure (by Region), FY2012-FY2013 
BD's Medical Revenue (by Product), FY2011-FY2013
Gerresheimer’s Revenue Structure (by Consumer Market), 2012
Gerresheimer’s Revenue and Operating Profit, 2009-2013
Gerresheimer’s Revenue (by Business), 2009-2013 
Gerresheimer’s Revenue Structure (by Region), 2012 
Schott’s Subsidiaries in China  
Nipro’s Revenue and Net Income, FY2010-FY2013 
Nipro’s Revenue Structure (by Business), FY2012-FY2013  
Nipro’s Revenue Structure (by Region), FY2013  
Nipro’s Glassware Revenue and % in Total Revenue, FY2012-FY2013
Nipro’s Main Subsidiaries and Business in China
Main Products of Shandong Pharmaceutical Glass  
Revenue and Net Income of Shandong Pharmaceutical Glass, 2008-2013
Operating Revenue of Shandong Pharmaceutical Glass (by Product), 2008-2013 
Operating Revenue of Shandong Pharmaceutical Glass (by Region), 2008-2013
Gross Margin of Shandong Pharmaceutical Glass (by Product), 2008-2013   
Revenue and Gross Margin of Shandong Pharmaceutical Glass (by Product), 2012-2016E   
Weigao’s Product Categories and Major Products
Weigao’s Revenue and Net Income, 2009-2013     
Weigao’s Sales and Distribution Network, 2012
Output of Weigao's Main Products, 2011-2013
Weigao’s Revenue Structure (by Product), 2009-2013 
Revenue Structure of Weigao’s Regular Medical Supplies, 2006-2013
Main High-value-added Products of Weigao’s Regular Medical Supplies
Weigao’s Revenue (by Region), 2008-2013
Weigao’s Prefilled Syringe Output and Sales Revenue, 2011-2013
Weigao’s Gross Margin, 2004-2013
Weigao’s R&D Costs and % of Total Revenue ,2008-2013
Weigao’s Patents and Registration Certificates, 2007-2013
Weigao’s Customers by Type, 2007-2013
Weigao’s Prefilled Syringe Output and Sales Revenue, 2011-2013
Weigao’s Revenue and Net Income, 2012-2016

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

China Pharmaceutical Chain Industry Report, 2010

Recent years have seen rapid growth of China’s pharmaceutical retail market, with expanding scale of chain enterprises and increasing number of drugstores, thanks to a fast-growing pharmaceutical indu...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统